Fentanyl and Mavorixafor: Interaction Details
- Fentanyl
- AbstralActiqFentora +3 more
- Mavorixafor
- Xolremdi
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl and Mavorixafor interaction:
Fentanyl
- Abstral
- Actiq
- Fentora
- Onsolis
- Subsys
- Ionsys
Mavorixafor
- Xolremdi
We don't have a drug information page for Mavorixafor yet. Have a question about Mavorixafor? Ask a pharmacist, free →
What Happens When You Take Fentanyl With Mavorixafor
What can happen when they are taken together (rated Major)
Increased with NTI exposure and an increased risk of CYP3A4 with NTI-related adverse events
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When mavorixafor, a CYP3A4 , is given together with a CYP3A4 substrate that has a (NTI), exposure to that substrate may rise, which may raise the likelihood of adverse events linked to it. For CYP3A4 substrates in which even small shifts in concentration can cause serious adverse reactions, adverse reactions to the substrate should be monitored more often during with mavorixafor. A drug interaction study in healthy subjects found that giving mavorixafor 400 mg with midazolam (a CYP3A4 substrate) raised midazolam by 1.1-fold and by 1.7-fold.1
The Fentanyl and Mavorixafor Interaction, Explained
Mavorixafor can slow the way your body breaks down fentanyl, so more fentanyl may stay in your system. Fentanyl is a strong pain medicine that is cleared mainly by an enzyme called , and mavorixafor partly blocks that enzyme. Higher fentanyl levels can cause extra drowsiness, slowed or shallow breathing, confusion, and dizziness. Even small changes in fentanyl levels can matter, so this combination is taken seriously.
Your care team can manage this, for example by adjusting your fentanyl dose and checking on you more often. Keep taking your medicines as prescribed and talk with your pharmacist or doctor about it. Get urgent help if you have trouble breathing or are very hard to wake.
Mechanism: mavorixafor inhibits , the main pathway for fentanyl . Fentanyl is not a , so reduced means increased exposure and a greater risk of toxicity (, ).
- Magnitude: with midazolam (a sensitive CYP3A4 ), mavorixafor 400 mg raised 1.1-fold and 1.7-fold. No fentanyl-specific data are cited.
- Severity/evidence: major, probable evidence, onset unspecified.
- Management: monitor more frequently for CYP3A4 substrate adverse reactions, especially sedation and respiratory depression. The fentanyl dose may need individualized adjustment, particularly when it is started, changed, or stopped alongside mavorixafor.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl and Mavorixafor Interact
The likely mechanism
of -mediated by mavorixafor
How to Manage the Fentanyl and Mavorixafor Interaction
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Do not change doses on your own.
- Your care team may monitor you more closely for fentanyl side effects while you take mavorixafor.
- Your fentanyl dose may need to be adjusted and individualized by your care team.
- Tell your pharmacist or prescriber about all your medicines, including any you start or stop.
- Report unusual sleepiness, slow or shallow breathing, confusion, or dizziness right away. Seek emergency care for severe symptoms.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl or Mavorixafor need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: XOLREMDI oral capsules, mavorixafor oral capsules
A drug interaction study in healthy subjects found that giving mavorixafor 400 mg (a ) together with midazolam (a CYP3A4 ) raised midazolam by 1.1-fold and by 1.7-fold, respectively.1
Fentanyl and Mavorixafor: Common Questions
How serious is the Fentanyl and Mavorixafor interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl and Mavorixafor interaction managed?
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Do not change doses on your own. Your care team may monitor you more closely for fentanyl side effects while you take mavorixafor. Your fentanyl dose may need to be adjusted and individualized by your care team. Tell your pharmacist or prescriber about all your medicines, including any you start or stop. Report un… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fentanyl and Mavorixafor Interaction
Ask in your own words about taking Fentanyl and Mavorixafor together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: XOLREMDI(TM) oral capsules, mavorixafor oral capsules. X4 Pharmaceuticals, Inc. (Per FDA), Boston, MA, 2024. DailyMed
Other Serious Interactions of Fentanyl and Mavorixafor
Also serious with Fentanyl
- IsocarboxazidContraindicated
- LevoketoconazoleContraindicated
- NaltrexoneContraindicated
- PhenelzineContraindicated
Also serious with Mavorixafor
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Fentanyl
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- + 222 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.